Subject Index to Volume 12 A pathophysiology, 356 terazosin therapy, 389 A23187 transurethral incision of prostate and bladder neck for, 415 fix vital stain method to evaluate bovine sperm, 112 transurethral/transrectal microwave hyperthermia for, 429 induced acrosome reaction and fertility, 98 Bisbenzimide 33258 (H33258), fix vital stain method to evaluate Acid phosphatase, seminal plasma, as sperm quality marker, 191 bovine sperm, 112 Acrosome Bladder neck incision, in benign prostatic hyperplasia, 415 evaluation, fix vital stain method (bovine), 112 a-Blockers, in benign prostatic hyperplasia, 389 miniacrosome defect causing infertility in two brothers, 104 Buserelin, in prostatic cancer, circulating gonadotropin levels and, SP-10 protein, gene mapping, 281 46 stage-specific expression of acrosomal protein of baboon sperm during spermiogenesis, 140 c Acrosome reaction A23187-induced, fertility and, 98 bovine follicular fluid and oviduct fluids and, 244 Calcium effect of phorbol diesters, synthetic diacylglycerols, and protein acrosome reaction and, 62 kinase C inhibitor, 62 extracellular, testosterone production and (mouse), 148 Adenosine monophosphate, cyclic (cAMP), Leydig cell production, progesterone-stimulated intracellular accumulation, during in vitro LH/hCG receptor complex in, 132 capacitation of human sperm, 323 S-Adenosyl-L-methionine decarboxylase activity, epididymis, Calcium ionophore. See A23187 ontogeny and androgenic control (rat), 209 cAMP. See Adenosine monophosphate, cyclic Adrenal gland, androgen blockade, in prostate cancer, 364 Citric acid, semen content, in clinically silent genital tract a-Adrenergic antagonists, in benign prostatic hyperplasia, 389 inflammation, 331 Age/aging Clomiphene citrate, chronic administration, response of compensatory pituitary and testicular responses to hemicastration pituitary-testicular axis to, aging and, 258 (rat), 119 Clusterin, endocytosis, in efferent ducts and epididymis (ram), 288 pituitary-gonadal axis response to chronic clomiphene Computers, sperm motion analysis. See also Semen analysis, administration and, 258 computer-assisted Poisson distribution of sperm penetration, 71 issues in statistical analysis of data, 89 rapid development of Leydig cell tumors in Wistar rat substrain Cryopreservation, effect of sperm freezing and thawing on binding U, 171 capacity, 1 Albumin, seminal plasma, as sperm quality marker, 191 Cryptorchidism, experimental, electron microscopic Leydig cell Androgen(s) morphology (mouse), 335 control of epididymal S-adenosyl-L-methionine decarboxylase activity (rat), 209 in Wilson's disease, 180 D Androgen-binding protein, endocytosis, in efferent ducts and epididymis (ram), 288 Antiandrogens Diacylglycerol, acrosome reaction and, 62 in benign prostatic hyperplasia, 381 Dihydrotestosterone, regulatory actions on FSH secretion and in prostate cancer, overview, 364 clearance, 27 Aromatase inhinitors, in benign prostatic hyperplasia DNA, ventral prostate, 4-MAPC and (rat), 315 animal studies, 395, 403 human studies, 403 Asthenospermia, testicular steroidogenesis in, 273 E Atamestane, in benign prostatic hyperplasia animal studies, 395, 403 Electroejaculation, pentoxifylline stimulation of sperm motion in human studies, 403 men undergoing electroejaculation, 165 Electron microscopy, Leydig cell morphology, experimental cryptorchidism (mouse), 335 B Electron paramagnetic resonance spectroscopy, sperm membrane lipids, protein and physical state during epididymal maturation Benign prostatic hyperplasia, 346 (rat), 76 antiandrogen therapy, 381 Electrophoresis, lactoferrin, albumin, and acid phosphatase ratios in aromatase inhibitors for (animals), 395, 403 seminal plasma from fertile and infertile men, 191 atamestane therapy (animals), 395, 403 Enzyme inhibitors, in prostate cancer, overview, 364 atamestane therapy (humans), 403 Epichlorohydrin intoxication, sperm motion and fertility and (rat), a-blocker therapy, 389 54 development, 348 Epididymis editorial, 345 S-adenosyl-L-methionine decarboxylase activity, ontogeny and finasteride therapy, 372 androgenic control (rat), 209 flutamide therapy, 376 endocytosis of testicular proteins (ram), 288 histogenesis, 348 sperm maturation intraurethral prostatic stent for, 423 monoclonal antibody study, 305 LHRH agonist therapy, 381 plasma membrane lipid and protein content and physical state origin, 348 during (rat), 76 438 Subject Index to Volume 12 A pathophysiology, 356 terazosin therapy, 389 A23187 transurethral incision of prostate and bladder neck for, 415 fix vital stain method to evaluate bovine sperm, 112 transurethral/transrectal microwave hyperthermia for, 429 induced acrosome reaction and fertility, 98 Bisbenzimide 33258 (H33258), fix vital stain method to evaluate Acid phosphatase, seminal plasma, as sperm quality marker, 191 bovine sperm, 112 Acrosome Bladder neck incision, in benign prostatic hyperplasia, 415 evaluation, fix vital stain method (bovine), 112 a-Blockers, in benign prostatic hyperplasia, 389 miniacrosome defect causing infertility in two brothers, 104 Buserelin, in prostatic cancer, circulating gonadotropin levels and, SP-10 protein, gene mapping, 281 46 stage-specific expression of acrosomal protein of baboon sperm during spermiogenesis, 140 c Acrosome reaction A23187-induced, fertility and, 98 bovine follicular fluid and oviduct fluids and, 244 Calcium effect of phorbol diesters, synthetic diacylglycerols, and protein acrosome reaction and, 62 kinase C inhibitor, 62 extracellular, testosterone production and (mouse), 148 Adenosine monophosphate, cyclic (cAMP), Leydig cell production, progesterone-stimulated intracellular accumulation, during in vitro LH/hCG receptor complex in, 132 capacitation of human sperm, 323 S-Adenosyl-L-methionine decarboxylase activity, epididymis, Calcium ionophore. See A23187 ontogeny and androgenic control (rat), 209 cAMP. See Adenosine monophosphate, cyclic Adrenal gland, androgen blockade, in prostate cancer, 364 Citric acid, semen content, in clinically silent genital tract a-Adrenergic antagonists, in benign prostatic hyperplasia, 389 inflammation, 331 Age/aging Clomiphene citrate, chronic administration, response of compensatory pituitary and testicular responses to hemicastration pituitary-testicular axis to, aging and, 258 (rat), 119 Clusterin, endocytosis, in efferent ducts and epididymis (ram), 288 pituitary-gonadal axis response to chronic clomiphene Computers, sperm motion analysis. See also Semen analysis, administration and, 258 computer-assisted Poisson distribution of sperm penetration, 71 issues in statistical analysis of data, 89 rapid development of Leydig cell tumors in Wistar rat substrain Cryopreservation, effect of sperm freezing and thawing on binding U, 171 capacity, 1 Albumin, seminal plasma, as sperm quality marker, 191 Cryptorchidism, experimental, electron microscopic Leydig cell Androgen(s) morphology (mouse), 335 control of epididymal S-adenosyl-L-methionine decarboxylase activity (rat), 209 in Wilson's disease, 180 D Androgen-binding protein, endocytosis, in efferent ducts and epididymis (ram), 288 Antiandrogens Diacylglycerol, acrosome reaction and, 62 in benign prostatic hyperplasia, 381 Dihydrotestosterone, regulatory actions on FSH secretion and in prostate cancer, overview, 364 clearance, 27 Aromatase inhinitors, in benign prostatic hyperplasia DNA, ventral prostate, 4-MAPC and (rat), 315 animal studies, 395, 403 human studies, 403 Asthenospermia, testicular steroidogenesis in, 273 E Atamestane, in benign prostatic hyperplasia animal studies, 395, 403 Electroejaculation, pentoxifylline stimulation of sperm motion in human studies, 403 men undergoing electroejaculation, 165 Electron microscopy, Leydig cell morphology, experimental cryptorchidism (mouse), 335 B Electron paramagnetic resonance spectroscopy, sperm membrane lipids, protein and physical state during epididymal maturation Benign prostatic hyperplasia, 346 (rat), 76 antiandrogen therapy, 381 Electrophoresis, lactoferrin, albumin, and acid phosphatase ratios in aromatase inhibitors for (animals), 395, 403 seminal plasma from fertile and infertile men, 191 atamestane therapy (animals), 395, 403 Enzyme inhibitors, in prostate cancer, overview, 364 atamestane therapy (humans), 403 Epichlorohydrin intoxication, sperm motion and fertility and (rat), a-blocker therapy, 389 54 development, 348 Epididymis editorial, 345 S-adenosyl-L-methionine decarboxylase activity, ontogeny and finasteride therapy, 372 androgenic control (rat), 209 flutamide therapy, 376 endocytosis of testicular proteins (ram), 288 histogenesis, 348 sperm maturation intraurethral prostatic stent for, 423 monoclonal antibody study, 305 LHRH agonist therapy, 381 plasma membrane lipid and protein content and physical state origin, 348 during (rat), 76 438 Index to Volume 12 439 Estradiol H inhibition of Leydig cell regeneration in EDS-treated rat, 295 in Leydig cell tumors in Wistar rat substrain U, 171 Hamilton-Thom Motility Analyzer, sperm motility assessment, regulatory actions on FSH secretion and clearance, 27 prediction of IVF rates and, 231 Estrogen, in prostate cancer, 364 hCG stimulation test Ethane dimethylsulfonate (EDS), Leydig cell regeneration and (rat), in idiopathic oligoasthenospermia, 273 295 in Wilson’s disease, 180 Excurrent ducts, endocytosis of testicular proteins (ram), 288 Hemicastration compensatory pituitary and testicular responses, prepubertal vs mature rats, 119 F FSH concentration and testosterone secretion in, follicular fluid administration and (rat), 221 Hemizona assay, functional aspects of human sperm binding, 1 Famesyl pyrophosphate synthetase mRNA, testicular, pituitary 2,5-Hexanedione intoxication, Sertoli cell, germ cell repopulation regulation in sexually maturing rat, 264 and (rat), 18 Fertility/infertility 3P-Hydroxysteroid dehydrogenase/A*-A^ isomerase, in human correlation of sperm motion parameters with fertility in testis, ontogeny of, 161 epichlorohydrin-treated rats, 54 Hyperplasia, prostate. See Benign prostatic hyperplasia evaluation, relationship between hypo-osmotic swelling test and Hyperthermia, microwave, transurethral/transrectal, for benign sperm penetration assay, 152 prostatic hyperplasia, 429 induced acrosome reaction and, 98 Hypogonadism lactoferrin, albumin and acid phosphatase seminal levels as sperm diurnal rhythm of testosterone and LH, 185 quality markers, 191 hypergonadotropic, in men bom with benign sacrococcygeal miniacrosome defect causing infertility in two brothers, 104 teratoma, 226 Fertilization, A23187-induced acrosome reaction and, 98 Hypo-osmotic swelling (HOS) test, in fertility evaluation, relation Fertilization in vitro, rate, relation to sperm motility as assessed by to sperm penetration assay, 152 Hamilton-Thom Motility Analyzer, 231 Hypothalamic-pituitary-testicular axis, in Wilson’s disease, Finasteride, in benign prostatic hyperplasia, 372 functional assessment, 180 Fix vital stain method, simultaneous determination of viability and acrosomal status of bovine sperm, 112 Rutamide I in benign prostatic hyperplasia. 376 in prostate cancer, 364 Follicle-stimulating hormone (FSH) Immunocytochemistry, ontogeny of 3 P-hydroxysteroid response to GnRH agonist treatment in prostatic cancer, 46 dehydrogenase/A®-A”* isomerase in human testis, 161 response to hemicastration, prepubertal vs mature rats, 119 Immunofluorometric assay (IFMA), GnRH agonist treatment in secretion and clearance, dihydrotestosterone and estradiol and, 27 prostatic cancer, circulating gonadotropin levels and, 46 serum bioactive and immunoreactive levels, in hemicastrated rat, Immunoradiometric assay (IRMA), regulatory actions of sex follicular fluid administration and, 221 steroids on FSH secretion and clearance, 27 steroidogenesis and, Leydig tumor cell-Sertoli cell interactions Inflammation, genital tract, clinically silent, 331 (rat), 9 Inhibin Follicular fluid chronic clomiphene administration and, effects of aging, 258 effects on serum bioactive and immunoreactive FSH and in hemicastrated rat, follicular fluid administration and, 221 testosterone secretion, in hemicastrated rat, 221 in Leydig cell tumors in Wistar rat substrain U, 171 sperm capacitation and acrosome reaction and (bovine), 244 response to hemicastration, prepubertal vs mature rats, 119 Fructose, semen content, in clinically silent genital tract Insulin-like growth factor I, steroidogenesis and, Leydig tumor inflammation, 331 cell-Sertoli cell interactions (rat), 9 IVF. See Fertilization in vitro G K Gamete intrafallopian transfer (GIFT), pentoxifylline stimulation of Ketoconazole, in prostate cancer, 364 sperm motion in men undergoing electroejaculation, 165 Gene mapping, human intra-acrosomal protein SP-10, 281 Genital tract inflammation, clinically silent, biochemical markers L of, 331 Germ cell congenital defect, testicular dysfunction and, 226 Lactoferrin, seminal plasma, as sperm quality marker, 191 repopulation, 2,5-hexanedione exposure and (rat), 18 Leydig cells GnRH test, in Wilson’s disease, 180 cAMP production, LH/hCG receptor complex in, 132 Gonadotropin(s) electron microscopic morphology, in experimental cryptorchidism chronic clomiphene administration and, effects of aging, 258 (mouse), 335 human chorionic (hCG). See also hCG stimulation test mitosis, in adult guinea pig, 240 Leydig cell production of cAMP/testosterone and, 132 regeneration, in EDS-treated rat, 17a-estradiol inhibition of, 295 in Wilson’s disease, 180 steroidogenesis, Leydig tumor cell-Sertoli cell interactions (rat), 9 Gonadotropin-releasing hormone (GnRH) agonists. See Buserelin testosterone production Granulocyte elastase, semen content, in clinically silent genital tract extracellular calcium and (mouse), 148 inflammation, 331 LH/hCG receptor complex in, 132 440 Journal of Andrology ■ November/December 1991 tumors, rapid development in Wistar rat substrain U, 171 Pituitary-testicular axis, response to chronic clomiphene LHRH agonists, in benign prostatic hyperplasia, 381 administration, aging and, 258 Lipid(s), sperm plasma membrane, during epididymal maturation Poisson distribution, sperm penetration of zona-free hamster ova, 71 (rat), 76 Progesterone, intracellular calcium accumulation and, during in Liver disease, endocrine studies in Wilson’s disease, 180 vitro capacitation of human sperm, 323 Luteinizing hormone (LH) Prostate cancer bioactive, response to GnRH agonist treatment in prostatic buserelin therapy, circulating gonadotropin levels and, 46 cancer, 46 enzyme inhibitors and antiandrogens in, overview, 364 diurnal rhythm, in hypogonadism, 185 Prostate gland Leydig cell production of cAMP/testosterone and, 132 in clinically silent genital tract inflammation, 331 response to GnRH agonist treatment in prostatic cancer, 46 enlargement. See Benign prostatic hyperplasia response to hemicastration, prepubertal vs mature rats, 119 transurethral incision, in benign prostatic hyperplasia, 415 ventral, weight, DNA, and prostatein content, 4-MAPC and (rat), 315 M volume, in benign prostatic hyperplasia, flutamide therapy and, 376 4-MAPC, ventral prostate weight, DNA, and prostatein content and Prostatein, ventral prostate, 4-MAPC and (rat), 315 (rat), 315 Prostate-specific antigen, in benign prostatic hyperplasia, flutamide Megestrol, in prostate cancer, 364 therapy and, 376 Microscopy, Leydig cell mitosis (guinea pig), 240 Prostatism. See Benign prostatic hyperplasia Microwave hyperthermia, transurethral/transrectal, for benign Prosthesis, intraurethral stent for benign prostatic hyperplasia, 423 prostatic hyperplasia, 429 Protein(s) Miniacrosome defect, infertility and, 104 sperm plasma membrane, during epididymal maturation (rat), 76 Mitosis, Leydig cells, in adult guinea pig, 240 testicular, endocytosis, in efferent ducts and epididymis (ram), Monoclonal antibody studies 288 sperm maturation during epididymal transit, 305 Protein kinase C, acrosome reaction and, 62 stage-specific expression of acrosomal protein of baboon sperm Puberty, testicular famesyl pyrophosphate synthetase mRNA, during spermiogenesis, 140 pituitary regulation (rat), 264 mRNA, testicular famesyl pyrophosphate synthetase, pituitary regulation (rat), 264 R N 5a-Reductase inhibitor. See Finasteride; 4-MAPC National Institute of Diabetes and Digestive and Kidney Diseases, polypeptide hormones, subunits, and antisera available for s research, 159 Neutral a-glucosidase, semen content, in clinically silent genital Semen, biochemical markers of clinically silent genital tract tract inflammation, 331 inflammation, 331 Semen analysis computer-assisted 0 statistical analysis of sperm motion data from, 89 variation of sperm motility parameters, 126 Oligoasthenospermia, idiopathic, testicular steroidogenesis in, 273 marmoset semen, 214 Ontogeny Seminal plasma S-adenosyl-L-methionine decarboxylase activity in rat epididymis, lactoferrin, albumin, and acid phosphatase ratios, in fertile and 209 infertile men, 191 baboon sperm acrosome region during testicular spermiogenesis, separation of cryopreserved human semen, Sephadex method, 140 201 3P-hydroxysteroid dehydrogenase/isomerase in human Sephadex column method, separation and concentration of motile testis, 161 cryopreserved sperm, 201 Oviduct fluid, sperm capacitation and acrosome reaction and Sertoli cell, 2,5-hexanedione intoxication, germ cell repopulation (bovine), 244 and (rat), 18 Ovum(a), zona-free (hamster), sperm penetration of. See also Sertoli cell factor, steroidogenesis and, Leydig tumor cell test Sperm penetration assay system (rat), 9 teratospermia and (cat), 36 Sex steroids, regulatory actions on FSH secretion and clearance, 27 Sexual maturation, testicular famesyl pyrophosphate synthetase mRNA and (rat), 264 P Spermatogenesis SP-10 protein, 281 Pentoxifylline, stimulation of sperm motion in men undergoing stage-specific expression of acrosomal protein of baboon sperm electroejaculation, 165 during spermiogenesis, 140 Phorbol diesters, acrosome reaction and, 62 Spermatogonia, 2,5-hexanedione exposure and (rat), 18 Pituitary gland Spermatozoa regulation of famesyl pyrophosphate synthetase mRNA in testes abnormalities, in men bom with benign sacrococcygeal teratoma, of sexually maturing rat, 264 226 response to hemicastration, prepubertal vs mature rats, 119 acrosome. See Acrosome; Acrosome reaction Index to Volume 12 441 capacitation, hyperactivated sperm motility and, 253 in idiopathic oligoasthenospermia, 273 capacitation in vitro Leydig tumor cell-Sertoli cell interactions (rat), 9 bovine follicular fluid and oviduct fluids and, 244 intracellular calcium accumulation and responsiveness to progesterone and, 323 T cryopreserved. See also Cryopreservation selection and concentration using Sephadex method, 201 Teratospermia, sperm function and (cat), 36 epiJidymal maturation Terazosin, in benign prostatic hyperplasia, 389 monoclonal antibody study, 305 Testis plasma membrane lipid and protein content and physical state androgen blockade, in prostate cancer, 364 during (rat), 76 atrophy, 2,5-hexanedione exposure and (rat), 18 function, teratospermia and (cat), 36 cAMP/testosterone production, LH/hCG receptor complex in, 132 miniacrosome defect, 104 chronic clomiphene administration and, effects of aging, 258 motion. See Sperm motility dysfunction, in men bom with benign sacrococcygeal teratoma, plasma membrane 226 lipid and protein content and physical state during epididymal electron microscopic morphology, in experimental cryptorchidism maturation (rat), 76 (mouse), 335 maturation changes during epididymal transit, monoclonal famesyl pyrophosphate synthetase mRNA in, pituitary regulation antibody study, 305 in sexually maturing rat, 264 viability and acrosomal status, fix vital stain method for ontogeny of 3 P-hydroxysteroid dehydrogenase/A®-A"* isomerase determination of (bovine), 112 in, 161 zona binding capacity proteins, endocytosis, in efferent ducts and epididymis (ram), 288 functional aspects. See Hemizona assay response to hemicastration, prepubertal vs mature rats, 119 teratospermia and (cat), 36 steroidogenesis Spermiogenesis, stage-specific expression of acrosomal protein of extracellular calcium and (mouse), 148 baboon sperm during, 140 in idiopathic oligoasthenospermia, 273 Sperm morphology Leydig tumor cell-Sertoli cell interactions (rat), 9 marmoset, 214 Testosterone sperm function in teratospermia and (cat), 36 diurnal rhythm, in hypogonadism, 185 Sperm motility Leydig cell production computer-assisted measurements extracellular calcium and (mouse), 148 statistical analysis, 89 LH/hCG receptor complex in, 132 variation of parameters, 126 response to GnRH agonist treatment in prostatic cancer, 46 correlation with fertility, in epichlorohydrin-treated rats, 54 response to hemicastration, prepubertal vs mature rats, 119 Hamilton-Thom Motility Analyzer assessment, prediction of IVF secretion, in hemicastrated rat, follicular fluid administration and, rates and, 231 221 hyperactivated serum level, in benign prostatic hyperplasia, flutamide therapy correlation to sperm penetration assay, 253 and, 376 zona binding capacity and, 1 in Wilson’s disease, 180 marmoset, 214 Thermotherapy, transurethral/transrectal microwave hyperthermia, pentoxifylline stimulation of sperm motion in men undergoing for benign prostatic hyperplasia, 429 electroejaculation, 165 Tolerization/immunosuppression protocol, monoclonal antibodies to variation of parameters, 126 maturation-specific sperm surface molecules, 305 Sperm penetration assay Transferrin, endocytosis, in efferent ducts and epididymis (ram), in fertility evaluation, relation to hypo-osmotic swelling test, 152 288 non-Poisson distribution of sperm from grandfathers, 71 relationship to hyperactivated sperm motility, 253 Sperm quality, lactoferrin, albumin, and acid phosphatase ratios in u seminal plasma and, 191 Spinal cord injury, GIFT in, pentoxifylline stimulation of sperm UroLume Wallstent, for benign prostatic hyperplasia, 423 motion in men undergoing electroejaculation, 165 Stains/staining, fix vital stain method, simultaneous determination of viability and acrosomal status of bovine sperm, 112 w Statistical analysis computer-assisted sperm motion data, 89 Wilson’s disease, assessment of hypothalamic-pituitary-testicular variation of sperm motility parameters, 126 function in, 180 Stent, intraurethral stent for benign prostatic hyperplasia, 423 Stereology Leydig cell mitosis (guinea pig), 240 z Leydig cell morphology, experimental cryptorchidism (mouse), 335 Steroidogenesis Zona pellucida extracellular calcium and (mouse), 148 sperm binding, functional aspects. See Hemizona assay hemicastration and, prepubertal vs mature rats, 119 sperm penetration of, teratospermia and (cat), 36 Author Index to Volume 12 A C Dupont, E., Luu-The, V., Labrie, F., Pelletier, G.: Ontogeny of 3/3-hy- Abney, T. O., Myers, R. B.: 17/8-Estra¬ Carlleau, J.: See Verhoeven, G. droxysteroid dehydrogenase/A’ - A"* diol inhibition of Leydigcell regener¬ Calandra, R. S.: 5^’ede las Heras, M. A. isomerase (3/3-HSD) in human testis ation in the ethane dimethylsulfo- Caitere, C. A.: See Scaglia, H. E. as studied by immunocytochemistry, nate-treated mature rat, 295 Casano, R.; See Baldi, E. 161 Abrescia, P.: See Sansone, G. Chakraborty, P. K.: See Brown, J. L. Amann, R. P.: See Veeramachaneni, Chamindrani Mendis-Handagama, E D. N. R. S. M. L.: Mitosis in normal adult Aquilano, D. R.: See Scaglia, H. E. guinea pig Leydig cells, 240 Eddy, R. L.: See Herr, J. C. Chan, S. Y. W.: See Wang, C. El Etreby, M. F.: Atamestane, a new B Chapin, R. E.; See Gladen, B. C. aromatase inhibitor for the manage¬ Baccetti, B., Burrini, A. G., Collodel, Christ, S. A.: See Toth, G. P. ment of benign prostatic hyperplasia, G., Piomboni, P., Renieri, T.: A Clejan, S. J.: See Stone, N. N. 403; see also Habenicht, U.-F. “miniacrosome” sperm defect caus¬ Coddington, C. C., Franken, D. R., Ensrud, K. M., Hamilton, D. W.: Use ing infertility in two brothers, 104 Burkman, L. J., Oosthuizen, W. T., of neonatal tolerization and chemi¬ Baker, H. W. G.: Relationship between Kruger, T., Hodgen, G. D.: Func¬ cal immunosuppression for the pro¬ sperm motility assessed with the Ha- tional aspects of human sperm bind¬ duction of monoclonal antibodies to milton-Thom motility analyzer and ing to the zona pellucida using the maturation-specific sperm surface fertilization rates in vitro, 231 hemizona assay, 1 molecules, 305 Baldi, E., Casano, R., Falsetti, C., Collodel, G.: See Baccetti, B. Krausz. C., Maggi, M., Forti, G.; In¬ Cui, K.-H., Flaherty, S. P., Newbie, F tracellular calcium accumulation C. D., Guerin, M. V., Napier, A. J., Falsetti, C.: See Baldi, E. and responsiveness to progesterone Matthews, C. D.: Collection and anal¬ Raherty, S. P.: See Cui, K.-H. in capacitating human spermatozoa, ysis of semen from the common Flickinger, C. J.: See Herr, J. C. 323 marmoset {Callithrix jacchus), 214 Forti, G.: See Baldi, E. Beitins, I. Z.: See Urban, R. J. Cummins, J. M., Pember, S. M., Je- Franken, D. R.: See Coddington, C. C. Bezold. G.: See Wolff, H. quier, A. M., Yovich, J. L., Hart¬ Frydman, M., Kauschansky, A., Bhalla. V. K.: See Browne, E. S. mann, P. E.; A test of the human Bonne-Tamir, B., Nassar, F., Hom- Blute, M. L., Lewis R. W.: Local micro- sperm acrosome reaction following burg, R.: Assessment of the hypotha¬ wave hyperthermia as a treatment al¬ ionophore challenge: Relationship to lamic-pituitary-testicular function ternative for benign prostatic hyper¬ fertility and other seminal parame¬ in male patients with Wilson’s dis¬ plasia, 429 ters, 98 ease, 180 Boekelheide, K., Hall, S. J., 2,5-Hex- Cunningham, G. R.: See Ghusn, H. F. anedione exposure in the rat results G D in long-term testicular atrophy de¬ Geller, J.: Overview of enzyme inhibi¬ spite the presence of residual sperma¬ Dahl, K. D.: See Brown, J. L.; see also tors and anti-androgens in prostatic togonia, 18 Urban, R. J. Bonne-Tamir, B.: See Frydman, M. de Jong, F. H.: See Teerds, K. J. cancer, 364 Ghusn, H. F., Shao, T. C., Klima, M., Bremner, W. J.: See Tenover, J. S. de Kretser, D. M.: See Mendis-Handa¬ Cunningham, G. R., 4-MAPC, a 5a- Brewer, L. D.; See Nazian, S. J. gama, S. M. L. C. reductase inhibitor, reduces rat ven¬ Brown, J. L., Chakraborty, P. K.; Com¬ de las Heras, M. A., Calandra, R. S.: tral prostate weight, DNA, and pros- parison of compensatory pituitary S-adenosyl-L-methionine decarbox¬ tatein concentrations, 315 and testicular responses to hemicas- ylase activity in the rat epididymis: Gladen, B. C., Williams, J., Chapin, tration between prepubertal and ma¬ Ontogeny and androgenic control, R. E.: Issues in the statistical analysis ture rats, 119 209 Brown, J. L., Dahl, K. D., Chakra¬ de Leeuw, A. M., den Daas, J. H. G., of sperm motion data derived from borty, P. K.: Effects of follicular fluid Woelders, H.: The fix vital stain computer-assisted systems, 89 administration on serum bioactive method: Simultaneous determina¬ Guerin, M. V.: See Cui, K.-H. and immunoreactive FSH concen¬ tion of viability and acrosomal status H trations and compensatory testoster¬ of bovine spermatozoa, 112 one secretion in hemicastrated adult den Daas, J. H. G.: See de Leeuw, Habenicht, U.-F., El Etreby, M. F.: Ra¬ rats, 221 A. M. tionale for using aromatase inhibi¬ Browne, E. S., Bhalla, V. K.; Does de Rooij, D. G.: See Teerds, K. J. tors to manage benign prostatic hy¬ gonadotropin receptor complex have Desjardins, C.: Editorial, 345 perplasia: Experimental studies, 395; an amplifying role in cAMP/testos- Doman, T.: See Hall, J. C. see also El Etreby, M. F. terone production in Leydig Cells?, Drobnis, E. Z., Zhong, C. Q., Over- Hadley, J.: See Hall, J. C. 132 street, J. W.: Separation of cryopre- Hall, J. C., Hadley, J., Doman, T.: Bruskewitz, R.; See Riehmann, M. served human semen using sephadex Correlation between changes in rat Burkman, L. J.: Sec Coddington, C. C. columns, washing, or percoll gra¬ sperm membrane lipids, protein, and Burrini, A. G.: See Baccetti, B. dients, 201 the membrane physical state during Bush, M.: See Howard, J. Dunkel, L.: See Lahdenne, P. epididymal maturation, 76 442 Index to Volume 12 443 Hall, S. J.: See Boekelheide, K. M P Hamilton, D. W.: See Ensrud, K. M. Mack, S. R., Zaneveld, L. J. D.; Effect Padmanabhan, V.: See Urban, R. J. Hartmann, P. E.: See Cummins, J. M. of phorbol diesters, synthetic diacyl- Parker, R. A.: See Rogers, B. J. Heikinheimo, M.: See Lahdenne, P. glycerols, and a protein kinase C in¬ Pelletier, G.: See Dupont, E. Hellstrom, W. J. G.; See Sikka, S. C. Henderson, D.: See El Etreby, M. F. hibitor on the human sperm acro¬ Pember, S. M.: See Cummins, J. M. some reaction, 62 Piomboni, P.: See Baccetti, B. Herr, J. C., Wright, R. M., Rickinger, Mag^, M.: See Baldi, E. C. J., Eddy, R. L., Shows, T. B.: As¬ Mariani, V. A.: See Scaglia, H. E. R signment of the gene for human in- Matthews, C. D.; See Cui, K.-H. tra-acrosomal protein SP-10 to the Rannikko, S.: See Huhtaniemi, 1. pi2 -•■ql3 region of chromosome McConnell, J. D.: The pathophysiol¬ Read, E. J.: See Toth, G. P. ogy of benign prostatic hyperplasia, 11,281 Reed, T. E.: See Zenzes, M. T. Hodgen, G. D.: See Coddington, C. C. 356 Renieri, T.: See Baccetti, B. Homburg, R.: See Frydman, M. McNutt, T. L., Killian, G. J.: Influence Rey-Valzacchi, G. J.: See Scaglia, H. E. of bovine follicular and oviduct Howard, J., Bush, M., Wildt, D. E.: Riehmann, M., Bruskewitz, R. C.: fluids on sperm capacitation in vitro, Teratospermia in domestic cats com¬ Transurethral incision of the pros¬ promises penetration of zona-free 244 tate and bladder neck, 415 hamster ova and cat zonae pelluci- Meikle, A. W., Liu, X., Stringham, Rogers, B. J., Parker, R. A.: Relation¬ J. D.: Extracellular calcium and lu¬ dae, 36 ship between the human sperm teinizing hormone effects on 22-hy- Huhtaniemi, 1., Venho, P., Jacobi, G., hypo-osmotic swelling test and Rannikko, S.: Response of circulat¬ droxycholesterol used for testoster¬ sperm penetration assay, 152 one production in mouse Leydig ing gonadotropin levels to GnRH ag¬ Rommerts, F. F. G.: See Teerds, K. J. cells, 148 onist treatment in prostatic cancer, Mendis-Handagama, S. M. L. C., Kerr, s 46 J. B., de Kretser, D. M.: Experimen¬ Sansone, G., Abrescia, P.: Relative ra¬ I tal cryptorchidism in the adult tios of lactoferrin, albumin, and acid mouse: 111. Qualitative and quantita¬ Isahakia, M. A.: Stage-specific expres¬ tive electron microscopic morphol¬ phosphatase seminal levels as sperm sion of a protein of the acrosome of ogy of Leydig cells, 335 quality markers in fertile and infer¬ baboon sperm during spermiogene- Meurer, M.: See Wolff, H. tile men, 191 sis detected with a monoclonal anti¬ The MK-906 (Finasteride) Study Scaglia, H. E., Carrere, C. A., Mariani, body, 140 Group: One-year experience in the V. A., Zylbersztein, C. C., Rey-Val- zacchi. G. J., Kelly, E. E., Aquilano, treatment of benign prostatic hyper¬ J plasia with finasteride. 372 D. R.: Altered testicular hormone production in infertile patients with Jacobi. G.: See Huhtaniemi, 1. Myers, R. B.: See Abney, T. O. idiopathic oligoasthenospermia, 273 Jequier, A. M.: See Cummins, J. M. Schrader, S. M., Turner, T. W., Simon, N S. D.: Longitudinal study of semen K Napier. A. J.: Sec Cui, K.-H. quality of unexposed workers: Sperm Kauschansky, A.: See Frydman, M. Nassar, F.: See Frydman, M. motility characteristics, 126 Kelly, E. E.: See Scaglia, H. E. Nazian, S. J., Brewer, L. D., Ness, Shao, T. C.: See Ghusn, H. F. Kerr, J. B.: See Mendis-Handagama, G. C.: Pituitary regulation of the ex¬ Shows, T. B.: See Herr, J. C. S. M. L. C. pression of the farnesyl pyrophos¬ Siimes, M. A.: See Lahdenne, P. Killian, G. J.; See McNutt, T. L. phate synthetase gene in the testes of Sikka. S. C., Hellstrom, W. J. G.: The Klima, M.: SeeGhusn, H. F. the sexually maturing rat. 264 application of pentoxifylline in the Koskimies, A. 1.: See Lahdenne, P. Ness, G. C.: See Nazian, S. J. stimulation of sperm motion in men Krausz, C.: See Baldi, E. Newbie, C. D.: See Cui, K.-H. undergoing electroejaculation, 165 Kruger, T.: See Coddington, C. C. Ng, V.: See Wang, C. Simon, S. D.: See Schrader, S. M. Nieschlag, E.: See Zenzes, M. T. Smith, M. K.: See Toth, G. P. L Nishino, Y.: See El Etreby, M. F. Stober, J. A.: See Toth, G. P. Labrie, F.: See Dupont, E. Stone, N. N., Clejan, S. J.: Response of Lahdenne, P., Dunkel, L., Heikin¬ 0 prostate volume, prostate-specific heimo, M., Koskimies, A. L, Siimes, Oesterling. J. E., Lewis R. W.: Intro¬ antigen, and testosterone to fluta- M. A.; Hypergonadotropic hypogo¬ duction, 346 mide in men with benign prostatic nadism and sperm abnormalities in Oesterling, J. E.: LHRH agonists: A hyperplasia, 376 men born with benign sacrococcy¬ nonsurgical treatment for benign Stringham, J. D.: See Meikle, A. W. geal teratoma, 226 prostatic hyperplasia, 381 T Lee, K.-F.: See Wang, C. Oesterling, J. E.: The origin and devel¬ Lepor, H.; The emerging role of alpha opment of benign prostatic hyperpla¬ Teerds, K. J., de Rooij, D. G., de Jong, antagonists in the therapy of benign sia: An age-dependent process, 348 F. H., Rommerts, F. F. G.: Rapid de¬ prostatic hyperplasia, 389 Oesterling, J. E.: A permanent, epithe- velopment of Leydig cell tumors in a Leung, A.; See Wang, C. lializing stent for the treatment of be¬ Wistar rat substrain, 171 Leung, J.; See Wang, C. nign prostatic hyperplasia: Prelimi¬ Tenover, J. S., Bremner, W. J.: The ef¬ Lewis, R.: See Blute, M. L.; see also nary results, 423 fects of normal aging on the response Oesterling, J. E. Oosthuizen, W. T.: See Coddington, of the pituitary-gonadal axis to Liu, X.: See Meikle, A. W. C. C. chronic clomiphene administration Luu-The, V.; See Dupont, E. Overstreet, J. W.: See Drobnis, E. Z. in men, 258 444 Journal of Andrology • November/December 1991 Toth. G. P., Stober, J. A., Zenick, H., in the efferent ducts and epididymis Woelders, H.: Sccde Leeuw, A. M. Read, E. J., Christ, S. A., Smith, of the ram, 288 Wolff, H., Bezold, G., Zebhauser, M., M. K.: Correlation of sperm motion Veldhuis, J. D.; See Urban, R. J. Meurer, M.; Impact of clinically si¬ parameters with fertility in rats Venho, P.: See Huhtaniemi, I. lent inflammation on male genital treated subchronically with epichlo- Verhoeven, G., Cailleau, J.: Rat tumor tract organs as reflected by biochemi¬ rohydrin, 54 Leydig cells as a test system for the cal markers in semen, 331 Tsoi, W.-L.: See Wang, C. study of sertoli cell factors that stimu¬ Wright, R. M.: See Herr, J. C. Turner, T. W.: See Schrader, S. M. late steroidogenesis, 9 Y u W Yovich, J. L.: See Cummins, J. M. Wang, C., Leung, A., Tsoi, W.-L., Urban, R. J., Dahl, K. D., Padmanab- Leung, J., Ng, V., Lee, K.-F., Chan, z han, V., Beitins, 1. Z., Veldhuis, S. Y. W.: Evaluation of human J. D.: Specific regulatory actions of sperm hyperactivated motility and Zaneveld, L. J. D.: See Mack, S. R. dihydrotestosterone and estradiol on its relationship with the zona-free Zebhauser, M.: See Wolff, H. the dynamics of FSH secretion and hamster oocyte sperm penetration Zenick, H.: See Toth, G. P. clearance in humans, 27 assay, 253 Zenzes, M. T., Reed. T. E., Nieschlag. Wildt, D. E.: See Howard. J. E.: Non-poisson distribution of V Williams. J.; SccGladen, B. C. sperm from grandfathers in zona- Veeramachaneni, D. N. R., Amann, Winters. S. J.: Diurnal rhythm of tes¬ free hamster ova. 71 R. P.: Endocytosis of androgen-bind¬ tosterone and luteinizing hormone Zhong, C. Q.: See Drobnis, E. Z. ing protein, clusterin, and transferrin in hypogonadal men, 185 Zylbersztein, C. C.; See Scaglia, H. E. STATEMENT OF OWNERSHIP, MANAGEMENT AND CIRCULATION (Act of August 12, 1970: Section 3685, Title 39 United States Code) Date of Filing— October 1,1991. Title of Publication—JOURNAL OF ANDROLOGY; Frequency of Issue—Bi-Monthly; Annual Subscription Price—$175.00; Location of Known Office of Publication—100 Insurance Way, Suite 114, Hagerstown, MD 21740; Location of Headquarters or General Business Offices of the Publisher— J. B. Lippincott Company, 227 East Washington Square, Philadelphia, PA 19106; Publisher—The American Society of Andrology, 309 W. Clark Street, Champaign, IL 61820; Editor—Claude Desjardins, MD, Department of Physiology, Box 449 Medical Center, Univ. of Virginia, Charlottesville, VA 22908; Managing Editor—Lynda Krumpholz, 227 East Washington Square, Philadelphia, PA 19106; Owner—American Society of Andrology, 309 W. Clark St., Champaign, IL 61820; Known Bondholders, Mortgagees, and other security holders owning or holding 1 percent or more of total amount of bonds, mortgages, or other securities—none. A. Total no. copies printed (net press run), average 1,635, actual 1,500; B. Paid circulation 1. Sales through dealers and carriers, street vendors and counter sales, average none, actual none; 2. Mail subscriptions, average 1099, actual 1153; C. Total paid circulation, average 1099, actual 1153; D. Free distribution by mail, carrier or other means. Samples complimentary, and other free copies, average 92, actual 46; E. Total distribution (sum of C and D), average 1191, actual 1199; F. Copies not distributed 1. Office use, leftover, unaccounted, spoiled after printing, average 444, actual 301, 2. Returns from news agents, none; G. Total (sum ofE& F—should equal net press run shown in A), average 1635, actual 1500.1 certify that the statements made by me above are correct and complete. J. Lippincott, Vice President. ■0